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Table. Parsimonious model with predictor variables and estimated odds-ratio
predicting BARC 1 or greater bleeding events.
Effect*
Odds
Ratio
Lower
Conﬁdence
Limit
Upper
Conﬁdence
Limit
Caucasian Race 2.85 2.14 3.79
Diabetes Mellitus 0.55 0.44 0.67
Female Sex 1.75 1.37 2.23
Warfarin therapy on admission 2.03 1.26 3.27
Use of Drug Eluting Stent 1.52 1.20 1.91
History of Chronic Lung Disease 1.66 1.20 2.28
Urgent PCI vs. Elective/Planned
PCI
0.77 0.62 0.94
Emergent PCI vs. Elective/Planned
PCI
1.02 0.56 1.87
Platelets (per 50,000 units/dl) 0.90 0.83 0.96
Body Mass Index (Kg/m2) per 5
unit increment
0.92 0.85 1.00
Current Smoker 0.79 0.61 1.02
Age (per 10 year increment) 0.91 0.83 1.01
Hemoglobin 13 to <15 vs.
Hemoglobin  15 (gm/dl)
1.19 0.94 1.51
Hemoglobin <13 vs. Hemoglobin
 15 (gm/dl)
1.13 0.86 1.50
STEMI 0.59 0.29 1.17
History of Peripheral Arterial
Disease
1.25 0.87 1.79
* We used Harrell’s backward selection strategy to select a parsimonious set of variables for
the ﬁnal model from a larger set of covariates selected a-priori. In this selection strategy,
variables with the smallest contribution to the model (by F-value) are sequentially eliminated
until further variable elimination leads to a greater than 5% loss in model prediction, as
compared with the initial fully adjusted model.
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Background: The use of drug-eluting stents necessitates prolonged dual antiplatelet
therapy after PCI, which increases patents’ risk for bleeding complications. However,
there are no models to predict long-term bleeding events in patients undergoing PCI.
Methods: A total of 3,128 PCI procedures in the multicenter PRISM study were
analyzed. Patient reported bleeding events were categorized by Bleeding Academic
Research Consortium (BARC) deﬁnitions; 0 (no-bleed), 1 (bleeding/bruising not
requiring treatment), 2 (bleeding that is actionable), or 3 (needing hospitalization/
transfusion). We used logistic regression to develop a model predicting BARC  1
bleeding. Discrimination and calibration were used to evaluate model performance. A
sensitivity analysis was performed for BARC 1 or greater bleeding events excluding
easy bruising.
Results: No bleeding and BARC 1, 2 and 3 bleeding were observed in 574
(18.4%); 2382 (76.2%); 114 (3.6%) and, 58 (1.8%) patients, respectively, at one
year. Compared with patients with no-bleeding, patients with BARC  1
bleeding were more often female (30 vs. 23%), and Caucasian (94 vs. 83%), and
had a higher incidence of DES implantation (83 vs. 76%) and warfarin therapy
(7.4 vs. 3.9%) and less diabetes (31 vs. 45%; p-value < 0.01 for all compari-
sons). The model discriminated well (c-statistic of 0.672), as did a more parsi-
monious model (table; c-statistic ¼ 0.669). There was excellent calibration
(Hosmer-Lemeshow; p¼0.915), indicating good ﬁt. Only easy bruising was
observed in 602 (19.2%) patients, and sensitivity analyses excluding easy
bruising from BARC  1 bleeding had slightly lower discrimination (c-statistic
0.621).
Covariates eligible for inclusion in the model: Age, sex, race, high school educa-
tion, no insurance, current smoker, history of peripheral arterial disease, history of
diabetes mellitus, history of chronic kidney disease, history of myocardial infarction,
prior PCI, history of heart failure, history of prior stroke, history of hypertension,
history of dyslipidemia,history of chronic lung disease, Chronic Kidney Disease (GFR
60, 30-59, <30 and dialysis), hemoglobin, platelet count, PCI indication (urgent,
emergent or elective/planned), STEMI vs. other indication presentation for PCI, use of
drug eluting stent, warfarin on admission, access site (radial, femoral or brachial) and
cardiac arrest on arrival.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/AngioplasConclusions: A large proportion of patients report bleeding complications after
PCI, and these can be predicted by pre-procedural characteristics. Estimates of
bleeding risk may help support shared decision-making with respect to stent
selection during PCI.
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Background: Complete revascularization (CR) is considered as a goal for percuta-
neous coronary intervention (PCI). Previous studies have proved that achieving CR is
beneﬁcial compared to incomplete CR. However there has been no research about the
long term outcome within CR patients.
Methods: From patients enrolled in the Efﬁcacy of Xience/Promus versus Cypher in
rEducing Late Loss after stENTing (EXCELLENT) registry, the SYNTAX score was
checked before and after PCI. The primary clinical outcome was 3-year patient-ori-
ented composite endpoint (POCE), which was a composite of all cause death, any
myocardial infarction, and any revascularization. Secondary outcomes were the in-
dividual components of 3-year POCE and 3-year target lesion failure (TLF). For
calculation of the clinical SS, the SS was multiplied with the value of the ‘Age,
Creatinine, and Ejection Fraction’ score.
Results: Among 5,102 patients from the EXCELLENT registry, 2,112 patients
achieved CR by PCI. 3-year POCE was less common in CR patients (10.0% vs.
16.9%, p< 0.001) and CR was an independent predictor of adverse outcomes
(Hazard ratio (HR) 1.326, 95% Conﬁdence Interval (CI) 1.108-1.587, p¼0.002).
Patients who achieved CR were divided into 3 groups, according to the pre-PCI
SYNTAX score (SS); 1low-SS< 6: 771 patients, 6mid-SS< 10: 692 patients, and
high-SS10: 649 patients. 3-year POCE increased signiﬁcantly along with increasing
baseline SS tertiles (7.5% vs. 8.4% vs. 14.8%, p< 0.001) and secondary outcomes
also showed similar tendency. Multivariate analysis showed that baseline SS was an
independent predictor of 3-year POCE (HR 1.032, 95% CI 1.011-1.053, p¼0.003 perty Overview and Outcomes B29
